Ownership history in BVF INC/IL · 22 quarters on record
This page tracks every 13F SEC filing in which BVF INC/IL reported a position in KYMERA THERAPEUTICS INC (KYMR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 5,502,710 | — | 0% | 14.41% | $428.2M | $77.81 |
| 2025 Q3 | UNCHANGED | 5,502,710 | — | 0% | 12.63% | $311.5M | $56.60 |
| 2025 Q2 | ADDED | 5,502,710 | +340,909 | +6.6% | 8.58% | $240.1M | $43.64 |
| 2025 Q1 | UNCHANGED | 5,161,801 | — | 0% | 5.76% | $141.3M | $27.37 |
| 2024 Q4 | UNCHANGED | 5,161,801 | — | 0% | 7.04% | $207.7M | $40.23 |
| 2024 Q3 | UNCHANGED | 5,161,801 | — | 0% | 7.15% | $244.3M | $47.33 |
| 2024 Q2 | UNCHANGED | 5,161,801 | — | 0% | 4.32% | $154.1M | $29.85 |
| 2024 Q1 | UNCHANGED | 5,161,801 | — | 0% | 5.70% | $207.5M | $40.20 |
| 2023 Q4 | ADDED | 5,161,801 | +422,797 | +8.9% | 3.29% | $131.4M | $25.46 |
| 2023 Q3 | UNCHANGED | 4,739,004 | — | 0% | 1.78% | $65.9M | $13.90 |
As of 2025 Q4 — sorted by position size